1. 206 An immune-competent tumor organoid platform to test novel immune checkpoint combinations targeting the receptor CD47 in triple negative breast cancer. (10th December 2020) Authors: Stirling, Elizabeth; Willey-Shelkey, Ethan; Wilson, Adam; Skardal, Aleksander; Triozzi, Pierre; Terabe, Masaki; Miller, Lance; Soker, Shay; Soto-Pantoja, David Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Another layer of immune complication in glioblastoma: inducible co-stimulator and its ligand. Issue 3 (7th January 2020) Authors: Terabe, Masaki; Gilbert, Mark R Journal: Neuro-oncology Issue: Volume 22:Issue 3(2020) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy. (4th May 2017) Authors: Terabe, Masaki; Robertson, Faith C.; Clark, Katharine; De Ravin, Emma; Bloom, Anja; Venzon, David J.; Kato, Shingo; Mirza, Amer; Berzofsky, Jay A. Journal: Oncoimmunology Issue: Volume 6:Number 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer. (October 2013) Authors: Berzofsky, Jay A; Wood, Lauren V; Terabe, Masaki Journal: Expert review of vaccines Issue: Volume 12:Number 10(2013) Page Start: 1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cancer vaccines: translation from mice to human clinical trials. (April 2018) Authors: Maeng, Hoyoung; Terabe, Masaki; Berzofsky, Jay A Journal: Current opinion in immunology Issue: Volume 51(2018) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Combining anti-CTLA4 with RG7787, an immunotoxin targeting mesothelin, promotes tumor eradication. (4th November 2015) Authors: Leshem, Jasmin; Liu, Xiu-fen; Bera, Tapan; Terabe, Masaki; Berzofsky, Jay A; Bossenmaier, Birgit; Niederfellner, Gerhard; Pastan, Ira Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Combining anti-CTLA4 with RG7787, an immunotoxin targeting mesothelin, promotes tumor eradication. Issue 2 (December 2015) Authors: Leshem, Jasmin; Liu, Xiu-fen; Bera, Tapan; Terabe, Masaki; Berzofsky, Jay; Bossenmaier, Birgit; Niederfellner, Gerhard; Pastan, Ira Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗